Funding for this research was provided by:
National Institutes of Health (HL095722)
Kenneth Rainin Foundation (Breakthrough Award)
MIT-GSK Gertrude B. Elion Postdoctoral Fellowship (MIT-GSK Gertrude B. Elion Postdoctoral Fellowship)
Text and Data Mining valid from 2019-03-27
First Online: 27 March 2019
: JMK has been a paid consultant in the field of regenerative medicine for companies including Stempeutics, Sanofi, Celltex, LifeVaultBio, Takeda, Quthero, and Mesoblast. JMK is also an inventor on a patent that was licensed to Mesoblast. JMK holds equity in Frequency Therapeutics, a company that has licensed IP generated by JMK that may benefit financially if the IP is further validated. The interests of JMK were reviewed and are subject to a management plan overseen by his institutions in accordance with their conflict of interest policies.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.